Literatura científica selecionada sobre o tema "CD2BP2"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "CD2BP2".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "CD2BP2"
Guo, Xiaobo, Gang Li, Yufeng Zhao e Bo Zhao. "TGFB Induced Factor Homeobox 2 Induces Deterioration of Bladder Carcinoma via Activating CD2 Cytoplasmic Tail Binding Protein 2". Journal of Biomedical Nanotechnology 19, n.º 9 (1 de setembro de 2023): 1670–76. http://dx.doi.org/10.1166/jbn.2023.3657.
Texto completo da fonteKofler, Michael, Kathrin Motzny, Michael Beyermann e Christian Freund. "Novel Interaction Partners of the CD2BP2-GYF Domain". Journal of Biological Chemistry 280, n.º 39 (6 de julho de 2005): 33397–402. http://dx.doi.org/10.1074/jbc.m503989200.
Texto completo da fonteHeinze, M., M. Kofler e C. Freund. "Investigating the functional role of CD2BP2 in T cells". International Immunology 19, n.º 11 (6 de setembro de 2007): 1313–18. http://dx.doi.org/10.1093/intimm/dxm100.
Texto completo da fonteAlbert, Gesa I., Christoph Schell, Karin M. Kirschner, Sebastian Schäfer, Ronald Naumann, Alexandra Müller, Oliver Kretz et al. "The GYF domain protein CD2BP2 is critical for embryogenesis and podocyte function". Journal of Molecular Cell Biology 7, n.º 5 (16 de junho de 2015): 402–14. http://dx.doi.org/10.1093/jmcb/mjv039.
Texto completo da fonteNielsen, Tine K., Sunbin Liu, Reinhard Lührmann e Ralf Ficner. "Structural Basis for the Bifunctionality of the U5 snRNP 52K Protein (CD2BP2)". Journal of Molecular Biology 369, n.º 4 (junho de 2007): 902–8. http://dx.doi.org/10.1016/j.jmb.2007.03.077.
Texto completo da fonteKofler, Michael, Katja Heuer, Tobias Zech e Christian Freund. "Recognition Sequences for the GYF Domain Reveal a Possible Spliceosomal Function of CD2BP2". Journal of Biological Chemistry 279, n.º 27 (22 de abril de 2004): 28292–97. http://dx.doi.org/10.1074/jbc.m402008200.
Texto completo da fonteAndujar-Sanchez, Montserrat, Eva S. Cobos, Irene Luque e Jose C. Martinez. "Thermodynamic Impact of Embedded Water Molecules in the Unfolding of Human CD2BP2-GYF Domain". Journal of Physical Chemistry B 116, n.º 24 (4 de junho de 2012): 7168–75. http://dx.doi.org/10.1021/jp303495b.
Texto completo da fontePiotukh, K., e C. Freund. "A novel hSH3 domain scaffold engineered to bind folded domains in CD2BP2 and HIV capsid protein". Protein Engineering Design and Selection 25, n.º 10 (17 de setembro de 2012): 649–56. http://dx.doi.org/10.1093/protein/gzs062.
Texto completo da fonteGan, Zhen, Bei Wang, Yishan Lu, Shuanghu Cai, Jia Cai, JiChang Jian e Zaohe Wu. "Molecular characterization and expression of CD2BP2 in Nile tilapia (Oreochromis niloticus) in response to Streptococcus agalactiae stimulus". Gene 548, n.º 1 (setembro de 2014): 126–33. http://dx.doi.org/10.1016/j.gene.2014.07.032.
Texto completo da fonteKang, Yuanyuan, Bhavita Patel, Kairong Cui, Keji Zhao, Yi Qiu e Suming Huang. "A T-Cell Specific Element Activates the TAL1 Oncogene Via an Interchromosomal Interaction During Leukemogenesis". Blood 120, n.º 21 (16 de novembro de 2012): 3507. http://dx.doi.org/10.1182/blood.v120.21.3507.3507.
Texto completo da fonteTeses / dissertações sobre o assunto "CD2BP2"
Mansour, Hala. "Characterization of GEXP15 as a potential regulator of protein phosphatase 1 in Plasmodium falciparum". Electronic Thesis or Diss., Université de Lille (2022-....), 2023. http://www.theses.fr/2023ULILS068.
Texto completo da fonteMalaria is one of the most prevalent vector-borne infectious diseases threatening 40% of the global population, causing around 300 million cases and 450,000 deaths annually, mostly affecting children under 5. With no effective vaccine and drug resistance emerging, there is an urgent need for innovative treatments. The malaria-causing Plasmodium parasite has a complex life cycle and unique cell division process. Compared to well-studied systems, limited knowledge of Plasmodium biology hampers therapeutic development. Protein phosphorylation, a key regulatory mechanism, is less understood in Plasmodium than in mammalian or yeast cells. Kinases and phosphatases involved in phosphorylation and dephosphorylation processes respectively are potential drug targets. The Protein Phosphatase type 1 catalytic subunit (PP1c) (PF3D7_1414400) operates in combination with various regulatory proteins to specifically direct and control its phosphatase activity. However, there is little information about this phosphatase and its regulators in the human malaria parasite, Plasmodium falciparum. To address this knowledge gap, we conducted a comprehensive investigation into the structural and functional characteristics of a conserved Plasmodium-specific regulator called Gametocyte EXported Protein 15, GEXP15 (PF3D7_1031600). Through in silico analysis, we identified three significant regions of interest in GEXP15: an N-terminal region hous-ing a PP1-interacting RVxF motif, a conserved domain whose function is unknown, and a GYF-like domain that potentially facilitates specific protein-protein interactions. To further elucidate the role of GEXP15, we conducted in vitro interaction studies that demonstrated a direct interaction between GEXP15 and PP1 via the RVxF-binding motif. This interaction was found to enhance the phosphatase activity of PP1. Additionally, utilizing a transgenic GEXP15-tagged line and live microscopy, we observed high expression of GEXP15 in late asexual stages of the parasite, with localization predominantly in the nucleus. Immunoprecipitation assays followed by mass spectrometry analyses revealed the interaction of GEXP15 with ribosomal- and RNA-binding proteins. Furthermore, through pull-down analyses of recombinant functional domains of His-tagged GEXP15, we confirmed its binding to PfPP1 and to the ribosomal complex via the GYF domain. Collectively, our study sheds light on the PfGEXP15-PP1-ribosome interaction, which plays a crucial role in protein translation. These findings suggest that PfGEXP15 could serve as a potential target for the development of malaria drugs
Oliveira, João Bosco Lucena de. "Determinação dos tensores polares de CH2C12/CD2C12 e os clorofluorcarbonos". [s.n.], 1991. http://repositorio.unicamp.br/jspui/handle/REPOSIP/249373.
Texto completo da fonteTese (doutorado) - Universidade Estadual de Campinas, Instituto de Quimica
Made available in DSpace on 2018-07-14T01:41:45Z (GMT). No. of bitstreams: 1 Oliveira_JoaoBoscoLucenade_D.pdf: 2836729 bytes, checksum: f689a1a625f22aa90eefb1f02c9d107d (MD5) Previous issue date: 1991
Doutorado
Monzo, Pascale. "Fonctions cellulaires de CD2AP et son implication dans la cytokinese". Nice, 2004. http://www.theses.fr/2004NICE4067.
Texto completo da fonteWalker, Jennifer Anne. "CD22, autoimmunity and the B cell". Thesis, University of Cambridge, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.612192.
Texto completo da fonteBarrett, Anna. "Molecular and cellular investigation of Alzheimer's disease associated risk loci : BIN1 and CD2AP". Thesis, Cardiff University, 2017. http://orca.cf.ac.uk/111373/.
Texto completo da fonteWöhner, Miriam [Verfasser], e Lars [Akademischer Betreuer] Nitschke. "Entwicklung einer knockin Mauslinie mit Expression von humanem CD22 zum Test therapeutischer Anwendungen künstlicher CD22-Liganden / Miriam Wöhner. Betreuer: Lars Nitschke". Erlangen : Universitätsbibliothek der Universität Erlangen-Nürnberg, 2012. http://d-nb.info/1024608700/34.
Texto completo da fonteBraae, Anne. "Exploring potential functional variants in the Alzheimer's disease associated genes, CD2AP, EPHA1 and CD33". Thesis, University of Nottingham, 2016. http://eprints.nottingham.ac.uk/33083/.
Texto completo da fonteBhatt, Arshiya [Verfasser]. "Unraveling details of CIN85/CD2AP assistance to SLP65-mediated B cell activation / Arshiya Bhatt". Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2020. http://d-nb.info/1217842810/34.
Texto completo da fonteKlein, Jörg. "Verwendung von Gene-Targeting-Techniken zur Etablierung neuer Mauslinien mit Mutationen in B-Zell-Signalwegen". [S.l.] : [s.n.], 2005. http://deposit.ddb.de/cgi-bin/dokserv?idn=976107953.
Texto completo da fonteMari, Muriel. "Caractérisation structurale et fonctionnelle de RABIP4 et CD2AP/CMS, deux effecteurs de la petite GTPase RAB4". Nice, 2002. http://www.theses.fr/2002NICE5727.
Texto completo da fonteLivros sobre o assunto "CD2BP2"
Books, Bchimak. Buchhaltung: Einfaches Einnahmen- und Ausgaben Kassenbuch Für Kleinunternehmen, Einfaches Buchhaltungsbuch Für Selbstständige, Freiberufler und Als Haushaltsbuch Für Die Buchhaltung, über 3300 Einträge Auf 120 Seiten). Cd22. Independently Published, 2021.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "CD2BP2"
Medway, Christopher, e Kevin Morgan. "CD2-Associated Protein (CD2AP)". In Genetic Variants in Alzheimer's Disease, 201–8. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7309-1_11.
Texto completo da fonteNewton, Dianne L., Luke H. Stockwin e Susanna M. Rybak. "Anti-CD22 Onconase: Preparation and Characterization". In Therapeutic Antibodies, 425–43. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-554-1_22.
Texto completo da fonteKreitman, Robert J., David J. P. FitzGerald e Ira Pastan. "BL22: A Milestone in Targeting CD22". In Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins, 151–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46877-8_8.
Texto completo da fonteTopp, Max, e Tobias Feuchtinger. "Management of Hypogammaglobulinaemia and B-Cell Aplasia". In The EBMT/EHA CAR-T Cell Handbook, 147–49. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94353-0_28.
Texto completo da fonteSmith, K. G. C., e D. T. Fearon. "Receptor Modulators of B-Cell Receptor Signalling — CD19/CD22". In Current Topics in Microbiology and Immunology, 195–212. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-57066-7_6.
Texto completo da fonteDrgona, Lubos, e Lucia Masarova. "CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4". In Infectious Complications in Biologic and Targeted Therapies, 89–112. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11363-5_6.
Texto completo da fonteBlasioli, J., e C. C. Goodnow. "Lyn/CD22/SHP-1 and Their Importance in Autoimmunity". In Current Directions in Autoimmunity, 151–60. Basel: KARGER, 2001. http://dx.doi.org/10.1159/000060551.
Texto completo da fonteCornall, R. J., C. C. Goodnow e J. G. Cyster. "Regulation of B Cell Antigen Receptor Signaling by the Lyn/CD22/SHP1 Pathway". In Current Topics in Microbiology and Immunology, 57–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-58537-1_5.
Texto completo da fonteFearon, Douglas T. "Non-Structural Determinants of Immunogenicity and the B Cell Co-Receptors, CD19, CD21, and CD22". In Advances in Experimental Medicine and Biology, 181–86. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5355-7_20.
Texto completo da fonteHan, Shoufa, Brian E. Collins e James C. Paulson. "Synthesis of 9-Substituted Sialic Acids as Probes for CD22-Ligand Interactions on B Cells". In ACS Symposium Series, 2–14. Washington, DC: American Chemical Society, 2007. http://dx.doi.org/10.1021/bk-2007-0960.ch001.
Texto completo da fonteTrabalhos de conferências sobre o assunto "CD2BP2"
Vasconcelos, D. N., A. C. F. Santos, M. A. MacDonald, M. M. Sant’Anna, B. N. C. Tenório, A. B. Rocha, V. Morcelle, N. Appathurai e L. Zuin. "Ultrafast dissociation of CD2Cl2 and CH2Cl2". In 25TH INTERNATIONAL CONFERENCE ON THE APPLICATION OF ACCELERATORS IN RESEARCH AND INDUSTRY. AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5127724.
Texto completo da fonteLe, Thuc Duy, Lin Liu, Emre Kiciman, Sofia Triantafyllou e Huan Liu. "The KDD 2022 Workshop on Causal Discovery (CD2022)". In KDD '22: The 28th ACM SIGKDD Conference on Knowledge Discovery and Data Mining. New York, NY, USA: ACM, 2022. http://dx.doi.org/10.1145/3534678.3542890.
Texto completo da fonteEggers, David F., W. Lewis-Bevan e M. C. L. Gerry. "Vibration-rotation infrared spectra of CHDF2". In OSA Annual Meeting. Washington, D.C.: Optica Publishing Group, 1986. http://dx.doi.org/10.1364/oam.1986.wj3.
Texto completo da fonteShah, Nirali N., Haneen Shalabi, Bonnie Yates, Constance Yuan, Haiying Qin, Amanda Ombrello, Hao-Wei Wang et al. "Abstract LB-146: Phase I CD22 CAR T-cell trial updates". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-lb-146.
Texto completo da fonteShah, Nirali N., Haneen Shalabi, Bonnie Yates, Constance Yuan, Haiying Qin, Amanda Ombrello, Hao-Wei Wang et al. "Abstract LB-146: Phase I CD22 CAR T-cell trial updates". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-lb-146.
Texto completo da fonteZanetti, SR, T. Velazco-Hernandez, F. Gutierrez-Agüera, H. Roca-Ho, D. Sánchez-Martínez, P. Petazzi, R. Torres et al. "CD19 and CD22-directed biespecific CAR for B-cell Acute Lymphoblastic Leukemia". In 32. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1687121.
Texto completo da fonteVitkina, Tatyana, Karolina Sidletskaya e Yulia Denisenko. "Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease". In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa3423.
Texto completo da fonteYao, Xin, Patricia Burke, Joyce O. Obidi, Xiaoru Chen, Haifeng Bao, Yihong Yao e Jiaqi Huang. "Abstract 4420: Factors potentially contributing to sensitivities of CD22-targeting agents in B-cell malignancies". In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4420.
Texto completo da fonteGouble, Agnès, Cécile Schiffer-Mannioui, Severine Thomas, Anne-Sophie Gautron, Laurent Poirot e Julianne Smith. "Abstract 3763: UCART22: allogenic adoptive immunotherapy of leukemia by targeting CD22 with CAR T-cells". In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3763.
Texto completo da fonteMussai, Francis J., Dario Campana, Deepa Bhojwani, Maryalice Stetler-Stevenson, Seth M. Steinberg, Sebastien Morisot, Curt I. Civin, Alan S. Wayne e Ira Pastan. "Abstract 4356: Cytotoxicity of the anti-CD22 immunotoxin HA22 against pediatric acute lymphoblastic leukemia (ALL)". In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-4356.
Texto completo da fonte